Brian Finrow, CEO of Lumen Bioscience on The Executive

by admin | Mar 10, 2023 | Press Release

Listen here

Lumen Bio: ‘We face 2023 with tremendous optimism’

by admin | Jan 16, 2023 | Press Release

Read More

Reporter’s Notebook: On Day 2 of J.P. Morgan, Start-Ups Soliciting Cash and VCs Eschewing High Risk

by admin | Jan 12, 2023 | Press Release

Read more

Lumen Bioscience Details 2022 Company and Facilities Growth, New Funding, and Clinical Pipeline Progress

by admin | Jan 5, 2023 | Press Release

-Progress across all commercial and charitable clinical research programs -Strong growth in headcount and facilities, including newly commissioned cGMP plant -$36 million in new funding in 2H2022, including major new research grants and equity Seattle, WA, January 5,...

Lumen Bioscience Receives Broad Funding Support for Advancement of Antibiotic Alternative for Preventing Traveler’s Diarrhea

by admin | Jan 4, 2023 | Press Release

Bill & Melinda Gates Foundation, Department of Defense and CARB-X Back Further Development of Spirulina-Based Therapeutics Seattle, WA, January 4, 2023 – Lumen Bioscience, a clinical-stage biotechnology company developing biologic drugs for highly prevalent...

Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs

by admin | Dec 27, 2022 | Press Release

Read more